Skip to main content
. 2017 Nov 28;16:483. doi: 10.1186/s12936-017-2130-3

Table 5.

Assumptions for the mass screening and treatment of imported cases in addition to Tables 2, 3 and 4

Parameter Value Unit
Years to scale up MSAT 1 Years
New coverage of MSAT 90 %
Sensitivity HS RDT (clinical infections) 99 %
Sensitivity HS RDT (asymptomatic, microscopically detectable) 87 %
Sensitivity HS RDT (asymptomatic, microscopically undetectable) 44 %

These parameters are from the “Interventions under trial: Focal MSAT (mobile)” tab in the modelling tool